Overview of impact of Brexit on Signant Health’s operations

December 31, 2020 marked the end of the Brexit transition period and the change to existing arrangements for the movement of goods between the United Kingdom (UK) and European Union (EU). 

Signant Health has updated the processes and operations in relation to the UK/EU Trade Deal which came into effect on 1 January 2021 for continuation of providing services and support to our customers.  

The primary changes relate to the shipment and return of devices, Data Privacy Agreements and Invoicing. 

To learn more about the specifics of how Brexit affects Signant Health’s operations, please contact your Signant Health representative directly or email Brexit@SignantHealth.com